YAMAZAKI Tomoo
Academic Assembly School of Medicine and Health Sciences Institute of Medicine
Shinshu University Hospital Clinical Division of Internal Medicine 2
Assistant Professor
Researcher Information
Web site
Research activity information
Award
Paper
- Acute-on-chronic liver failure in primary biliary cholangitis by exacerbation of autoimmune hepatitis features.
Yoshiaki Kobayashi; Takanobu Iwadare; Masayuki Ida; Chiaki Miyatsu; Yuki Yamashita; Tomoo Yamazaki; Kai Uehara; Takeshi Uehara; Yasuni Nakanuma; Takefumi Kimura
Clinical journal of gastroenterology, Aug. 2025
- Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease.
Noemí Cabré; Marcos F Fondevila; Wenchao Wei; Tomoo Yamazaki; Fernanda Raya Tonetti; Alvaro Eguileor; Ricard Garcia-Carbonell; Abraham S Meijnikman; Yukiko Miyamoto; Susan Mayo; Yanhan Wang; Xinlian Zhang; Thorsten Trimbuch; Seija Lehnardt; Lars Eckmann; Derrick E Fouts; Cristina Llorente; Hidekazu Tsukamoto; Peter Stärkel; Bernd Schnabl
The Journal of clinical investigation, 135(13), Jul. 2025 - Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy.
Takanobu Iwadare; Takefumi Kimura; Ayumi Sugiura; Taiki Okumura; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Tomoo Yamazaki; Satoru Joshita; Naoki Tanaka; Takeji Umemura
Journal of viral hepatitis, 32(4), e14025, Apr. 2025 - Acute alcohol-associated hepatitis: Latest findings in non-invasive biomarkers and treatment.
Tomoo Yamazaki; Bernd Schnabl
Liver international : official journal of the International Association for the Study of the Liver, 45(3), e15608, Mar. 2025 - Peroxisome proliferator-activated receptor delta and liver diseases.
Tomoo Yamazaki; Edward E Cable; Bernd Schnabl
Hepatology communications, 9(2), Feb. 2025 - Single‐Nuclei RNA Sequencing Shows the Engagement of PPAR‐Delta Target Genes Primarily in Hepatocytes and Cholangiocytes by the Selective PPAR‐Delta Agonist Seladelpar
Tomoo Yamazaki; Yongqiang Yang; David Schöler; Yoshimi Yukawa-Muto; Tetsuya Kouno; Aenne Harberts; Sadatsugu Sakane; Linton Freund; Cynthia L. Hsu; Thomas C. Whisenant; Sara Brin Rosenthal; Tatiana Kisseleva; Edward E. Cable; Bernd Schnabl
PPAR Research, Jan. 2025 - Serum Autotaxin Levels Predict Liver-Related Events in Patients With Primary Biliary Cholangitis: A Long-Term Multicenter Observational Study.
Takanobu Iwadare; Takefumi Kimura; Yuki Yamashita; Taiki Okumura; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Ayumi Sugiura; Tomoo Yamazaki; Satoshi Shimamoto; Koji Igarashi; Satoru Joshita; Takeji Umemura
Clinical and translational gastroenterology, 15(12), e00779, Dec. 2024 - Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis.
Tomoo Yamazaki; Tetsuya Kouno; Cynthia L Hsu; Phillipp Hartmann; Susan Mayo; Xinlian Zhang; Peter Stärkel; Francisco Bosques-Padilla; Elizabeth C Verna; Juan G Abraldes; Robert S Brown Jr; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie L Shawcross; Alexandre Louvet; Michael R Lucey; Philippe Mathurin; Guadalupe Garcia-Tsao; Ramon Bataller; Bernd Schnabl
Hepatology (Baltimore, Md.), 80(2), 403-417, Aug. 2024 - Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease.
Takanobu Iwadare; Takefumi Kimura; Taiki Okumura; Shun-Ichi Wakabayashi; Taro Nakajima; Shohei Kondo; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Naoyuki Fujimori; Tomoo Yamazaki; Hideo Kunimoto; Satoshi Shimamoto; Koji Igarashi; Satoru Joshita; Naoki Tanaka; Takeji Umemura
Communications medicine, 4(1), 73-73, Apr. 2024 - Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease.
Takefumi Kimura; Takanobu Iwadare; Shun-Ichi Wakabayashi; Seema Kuldeep; Tomoyuki Nakajima; Tomoo Yamazaki; Daiki Aomura; Hamim Zafar; Mai Iwaya; Satoru Joshita; Takeshi Uehara; Sai P Pydi; Naoki Tanaka; Takeji Umemura
Liver international : official journal of the International Association for the Study of the Liver, 44(2), 483-496, Feb. 2024 - Editorial: Multi-organ linkage pathophysiology and therapy for NAFLD and NASH.
Takefumi Kimura; Tomoo Yamazaki; Gabriel Rufino Estrela
Frontiers in endocrinology, 15, 1418066-1418066, 2024 - HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population.
Taiki Okumura; Satoru Joshita; Tomoo Yamazaki; Takanobu Iwadare; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Takefumi Kimura; Masao Ota; Takeji Umemura
Human immunology, 84(8), 401-407, Aug. 2023 - Symptom-based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease.
Shun-Ichi Wakabayashi; Satoru Joshita; Kazuhiro Kimura; Hirohiko Motoki; Taiki Okumura; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Takefumi Kimura; Koichiro Kuwahara; Takeji Umemura
JGH open : an open access journal of gastroenterology and hepatology, 7(8), 527-536, Aug. 2023 - A Diagnostic Impact of Serum Autotaxin Levels in Patients with Bone Marrow Fibrosis.
Hideyuki Nakazawa; Hiroko Kaiume; Koji Igarashi; Tomoo Yamazaki; Takeji Umemura; Naoko Asano; Takeshi Uehara; Fumihiro Ishida
Clinical lymphoma, myeloma & leukemia, 23(2), e117-e124, Feb. 2023 - Management of Rare Hemorrhage From Collateral Vessels During Gastrostomy Replacement Using Percutaneous Transhepatic Occlusion in Patient With Portal Hypertension.
Taiki Okumura; Takefumi Kimura; Tomoo Yamazaki; Takayuki Miyazawa; Yoshinori Tsukahara; Masahiro Kurozumi; Yugo Iwaya; Tadanobu Nagaya; Takeji Umemura
Gastro hep advances, 2(5), 652-655, 2023 - Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients.
Takanobu Iwadare; Takefumi Kimura; Naoki Tanaka; Tomoo Yamazaki; Shun-Ichi Wakabayashi; Taiki Okumura; Hiroyuki Kobayashi; Yuki Yamashita; Sai P Pydi; Tomoyuki Nakajima; Mai Iwaya; Ayumi Sugiura; Satoru Joshita; Takeshi Uehara; Takeji Umemura
Scientific reports, 12(1), 18900-18900, Nov. 2022 - Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD.
Takanobu Iwadare; Takefumi Kimura; Hideo Kunimoto; Naoki Tanaka; Shun-Ichi Wakabayashi; Tomoo Yamazaki; Taiki Okumura; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Satoru Joshita; Takeji Umemura
Biomedicines, 10(11), Nov. 2022 - 2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease.
Naoyuki Fujimori; Takefumi Kimura; Naoki Tanaka; Tomoo Yamazaki; Taiki Okumura; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Yuki Yamashita; Ayumi Sugiura; Jonathan Pham; Sai P Pydi; Kenji Sano; Satoru Joshita; Takeji Umemura
Hepatology research : the official journal of the Japan Society of Hepatology, 52(4), 352-363, Apr. 2022 - Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: Case report and review of the literature.
Tomoo Yamazaki; Satoru Joshita; Tetsuya Ichijo; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Yuki Yamashita; Ayumi Sugiura; Fumihiro Kawakami; Hideyuki Nakazawa; Takeji Umemura
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 27(12), 1750-1755, Dec. 2021 - Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients.
Satoru Joshita; Masao Ota; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Eiji Tanaka; Takeji Umemura
Scientific reports, 11(1), 21424-21424, Nov. 2021 - aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C.
Yuki Yamashita; Satoru Joshita; Ayumi Sugiura; Tomoo Yamazaki; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Yosuke Yamada; Soichiro Shibata; Hideo Kunimoto; Takanobu Iwadare; Makiko Matsumura; Chiharu Miyabayashi; Taiki Okumura; Sachie Ozawa; Yuichi Nozawa; Natsuko Kobayashi; Michiharu Komatsu; Naoyuki Fujimori; Hiromi Saito; Takeji Umemura
Hepatology research : the official journal of the Japan Society of Hepatology, 51(9), 933-942, Sep. 2021 - A Case of Liver Metastasis in Primary Renal Cell Carcinoma Diagnosed by Hepatectomy after 9 Years of Follow-up of Cystic Liver Lesion
SHIMIZU Yuki, SUGIURA Ayumi, JOSHITA Satoru, KOBAYASHI Hiroyuki, WAKABAYASHI Shun-ichi, YAMASHITA Yuki, YAMAZAKI Tomoo, UEHARA Takeshi, SHIMIZU Akira, SOEJIMA Yuji,UMEMURA Takeji
The Shinshu Medical Journal, 69(4), 209-215, Aug. 2021 - Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals.
Satoru Joshita; Yuki Yamashita; Toru Okamoto; Yoko Usami; Ayumi Sugiura; Tomoo Yamazaki; Akemi Kakino; Masao Ota; Tatsuya Sawamura; Takeji Umemura
Hepatology research : the official journal of the Japan Society of Hepatology, 51(7), 758-766, Jul. 2021 - Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients.
Takeji Umemura; Satoru Joshita; Hiromi Saito; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Masao Ota
Cancers, 13(13), Jun. 2021 - An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection.
Mizuki Koyama; Tomoo Yamazaki; Satoru Joshita; Akihiro Ito; Kazuyuki Ono; Takayuki Watanabe; Yuki Yamashita; Ayumi Sugiura; Mikiko Kobayashi; Yoshinori Sato; Masaharu Takahashi; Hiroaki Okamoto; Takeji Umemura
Internal medicine (Tokyo, Japan), 60(12), 1863-1870, Jun. 2021 - Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literature.
Yuki Yamashita; Satoru Joshita; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Ayumi Sugiura; Tomoo Yamazaki; Takeji Umemura
Medicina (Kaunas, Lithuania), 57(3), Mar. 2021 - Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD.
Takefumi Kimura; Naoki Tanaka; Naoyuki Fujimori; Tomoo Yamazaki; Takahito Katsuyama; Yuichi Iwashita; Jonathan Pham; Satoru Joshita; Sai P Pydi; Takeji Umemura
Liver international : official journal of the International Association for the Study of the Liver, 41(3), 505-514, Mar. 2021 - Adult Case of Acute Hepatitis Associated with Primary Cytomegalovirus Infection in Remission Phase of Crohn’s Disease
山崎智生; 城下智; 大野和幸; 菅智明; 小林浩幸; 若林俊一; 山下裕騎; 杉浦亜弓; 梅村武司; 梅村武司
信州医学雑誌, 69(3), 2021 - Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease.
Shun-Ichi Wakabayashi; Satoru Joshita; Kazuhiro Kimura; Hirohiko Motoki; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Koichiro Kuwahara; Takeji Umemura
PloS one, 16(4), e0249435, 2021 - Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project.
Hiroyuki Kobayashi; Satoru Joshita; Yuki Akahane; Katsuhiko Matsuzaki; Hiromi Yamada; Daiki Aomura; Nao Joshita; Hajime Midorikawa; Kazuhiro Suyama; Masao Ota; Shun-Ichi Wakabayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Hiromichi Misawa; Takeji Umemura
PloS one, 16(8), e0256711, 2021 - Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection.
Satoru Joshita; Ayumi Sugiura; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Akihiro Matsumoto; Yoko Usami; Eiji Tanaka
JGH open : an open access journal of gastroenterology and hepatology, 4(4), 574-581, Aug. 2020 - Polymorphism at rs9264942 is associated with HLA-C expression and inflammatory bowel disease in the Japanese.
Hiroshi Suzuki; Satoru Joshita; Atsuhiro Hirayama; Akihiro Shinji; Kenji Mukawa; Minako Sako; Naoki Yoshimura; Tomoaki Suga; Takeji Umemura; Norihiro Ashihara; Tomoo Yamazaki; Masao Ota
Scientific reports, 10(1), 12424-12424, Jul. 2020 - Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis.
Satoru Joshita; Yuki Yamashita; Ayumi Sugiura; Takeshi Uehara; Yoko Usami; Tomoo Yamazaki; Naoyuki Fujimori; Akihiro Matsumoto; Eiji Tanaka; Takeji Umemura
Journal of gastroenterology and hepatology, 35(7), 1208-1214, Jul. 2020 - Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases.
Ayumi Sugiura; Satoru Joshita; Yuki Yamashita; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Shuichi Wada; Hiromitsu Mori; Soichiro Shibata; Kaname Yoshizawa; Susumu Morita; Kiyoshi Furuta; Atsushi Kamijo; Akihiro Iijima; Satoko Kako; Atsushi Maruyama; Masakazu Kobayashi; Michiharu Komatsu; Makiko Matsumura; Chiharu Miyabayashi; Tetsuya Ichijo; Aki Takeuchi; Yuriko Koike; Yukio Gibo; Toshihisa Tsukadaira; Hiroyuki Inada; Yoshiyuki Nakano; Seiichi Usuda; Kendo Kiyosawa; Eiji Tanaka; Takeji Umemura
Biomedicines, 8(4), Apr. 2020 - Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus.
Naoyuki Fujimori; Naoki Tanaka; Takefumi Kimura; Kenji Sano; Akira Horiuchi; Naoyuki Kato; Yoshiyuki Takahashi; Naoya Kuribayashi; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Clinical journal of gastroenterology, 13(1), 83-89, Feb. 2020 - A case of multiple hepatocellular carcinoma tumors with thoracic vertebra and adrenal gland metastases successfully treated with prolonged administration of reduced-dose regorafenib for more than 12 months
岩垂隆諒; 山崎智生; 城下智; 藤森尚之; 金井圭太; 金井圭太; 山下裕騎; 高橋芳之; 杉浦亜弓; 梅村武司; 梅村武司
肝臓, 61(8), 2020 - Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis.
Satoru Joshita; Takeji Umemura; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Naoyuki Fujimori; Akihiro Matsumoto; Eiji Tanaka
Hepatology research : the official journal of the Japan Society of Hepatology, 49(10), 1236-1243, Oct. 2019 - Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study.
Takeji Umemura; Satoru Joshita; Soichiro Shibata; Ayumi Sugiura; Tomoo Yamazaki; Naoyuki Fujimori; Akihiro Matsumoto; Eiji Tanaka
Medicine, 98(6), e14475, Feb. 2019 - Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients.
Michiharu Komatsu; Naoki Tanaka; Takefumi Kimura; Naoyuki Fujimori; Kenji Sano; Akira Horiuchi; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Hepatology research : the official journal of the Japan Society of Hepatology, 48(13), 1092-1098, Dec. 2018 - Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals.
Ayumi Sugiura; Satoru Joshita; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Koji Igarashi; Yoko Usami; Shuichi Wada; Hiromitsu Mori; Soichiro Shibata; Kaname Yoshizawa; Susumu Morita; Kiyoshi Furuta; Atsushi Kamijo; Akihiro Iijima; Satoko Kako; Atsushi Maruyama; Masakazu Kobayashi; Michiharu Komatsu; Makiko Matsumura; Chiharu Miyabayashi; Tetsuya Ichijo; Aki Takeuchi; Yuriko Koike; Yukio Gibo; Toshihisa Tsukadaira; Hiroyuki Inada; Kendo Kiyosawa; Eiji Tanaka
Journal of viral hepatitis, 25(12), 1462-1471, Dec. 2018 - Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C.
Takeji Umemura; Tomoo Yamazaki; Satoru Joshita; Ayumi Sugiura; Naoyuki Fujimori; Akihiro Matsumoto; Masao Ota; Eiji Tanaka
Cytokine, 111, 357-363, Nov. 2018 - A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis.
Tomoo Yamazaki; Takeji Umemura; Satoru Joshita; Kaname Yoshizawa; Eiji Tanaka; Masao Ota
Scientific reports, 8(1), 11924-11924, Aug. 2018 - Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis.
Satoru Joshita; Takeji Umemura; Yoko Usami; Yuki Yamashita; Gary L Norman; Ayumi Sugiura; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Koji Igarashi; Kaname Yoshizawa; Masao Ota; Eiji Tanaka
Scientific reports, 8(1), 8159-8159, May 2018 - A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature.
Tomoo Yamazaki; Satoru Joshita; Eriko Kasuga; Kazuki Horiuchi; Ayumi Sugiura; Naoyuki Fujimori; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 24(5), 393-397, May 2018 - KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients.
Hiromi Saito; Takeji Umemura; Satoru Joshita; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka; Masao Ota
Oncotarget, 9(28), 19650-19661, Apr. 2018 - Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
Takefumi Kimura; Naoki Tanaka; Naoyuki Fujimori; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
World journal of gastroenterology, 24(13), 1440-1450, Apr. 2018 - Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.
Naoyuki Fujimori; Takeji Umemura; Takefumi Kimura; Naoki Tanaka; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Michiharu Komatsu; Yoko Usami; Kenji Sano; Koji Igarashi; Akihiro Matsumoto; Eiji Tanaka
World journal of gastroenterology, 24(11), 1239-1249, Mar. 2018 - Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection.
Satoru Joshita; Yuki Ichikawa; Takeji Umemura; Yoko Usami; Ayumi Sugiura; Soichiro Shibata; Tomoo Yamazaki; Naoyuki Fujimori; Michiharu Komatsu; Akihiro Matsumoto; Koji Igarashi; Masao Ota; Eiji Tanaka
Hepatology research : the official journal of the Japan Society of Hepatology, 48(4), 275-285, Mar. 2018 - Two Cases of Primary Biliary Cholangitis with Hepatocellular Carcinoma in a Non-cirrhotic Stage
SUGIURA Ayumi, JOSHITA Satoru, YAMASHITA Yuki, KIMURA Takefumi, YAMAZAKI Tomoo, FUJIMORI Naoyuki, KOMATSU Michiharu, MATSUMOTO Akihiro, KOBAYASHI Shota, UMEMURA Takeji, TANAKA Eiji
The Shinshu Medical Journal, 66(1), 39-49, Feb. 2018 - A case of hepatocellular carcinoma with iliac metastasis achieving complete long-term remission by multidisciplinary therapy with radiation therapy, transcatheter arterial chemoembolization, and sorafenib
若林俊一; 山崎智生; 城下智; 黒住昌弘; 杉浦亜弓; 藤森尚之; 柴田壮一郎; 市川雪; 森田進; 小松通治; 梅村武司; 松本晶博; 田中榮司
肝臓, 59(2), 2018 - Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.
Tomoo Yamazaki; Satoru Joshita; Takeji Umemura; Yoko Usami; Ayumi Sugiura; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Koji Igarashi; Masao Ota; Eiji Tanaka
PloS one, 13(4), e0195632, 2018 - Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury.
Naoyuki Fujimori; Michiharu Komatsu; Naoki Tanaka; Mai Iwaya; Hajime Nakano; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Yugo Iwaya; Takashi Muraki; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Clinical journal of gastroenterology, 10(5), 452-458, Oct. 2017 - Combination of Killer Immunoglobulin-like Receptor and HLA Genes is Associated with Hepatitis C Virus-Related Hepatocellular Carcinoma
Umemura, Takeji; Saito, Hiromi; Joshita, Satoru; Yamazaki, Tomoo; Tanaka, Eiji; Ota, Masao;
Oncotarget, 66, 124A-124A, Oct. 2017
- Two cases of non-cirrhotic primary biliary cirrhosis with complicating hepatocellular carcinoma
Sugiura, Ayumi; Joshita, Satoru; Yamashita, Yuki; Hihara, Yu; Fujimori, Naoyuki; Yamazaki, Tomoo; Maruyama, Yasuhiro; Shibata, Souichiro; Ichikawa, Yuki; Kimura, Takefumi; Ito, Tetsuya; Komatsu, Michiharu; Umemura, Takeji; Matsumoto, Akihiro; Tanaka, Eiji;
32, 186-186, Sep. 2017 - Association of serum autotaxin level with disease stage in Japanese patients with primary biliary cholangitis
Joshita, Satoru; Umemura, Takeji; Usami, Yoko; Sugiura, Ayumi; Yamazaki, Tomoo; Fujimori, Naoyuki; Komatsu, Michiharu; Matsumoto, Akihiro; Igarashi, Koji; Ota, Masao; Tanaka, Eiji;
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32, 179-179, Sep. 2017 - Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
Takeji Umemura; Tomohiro Sekiguchi; Satoru Joshita; Tomoo Yamazaki; Naoyuki Fujimori; Soichiro Shibata; Yuki Ichikawa; Michiharu Komatsu; Akihiro Matsumoto; Zakera Shums; Gary L Norman; Eiji Tanaka; Masao Ota
Liver international : official journal of the International Association for the Study of the Liver, 37(6), 897-905, Jun. 2017 - Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C.
Tomoo Yamazaki; Satoru Joshita; Takeji Umemura; Yoko Usami; Ayumi Sugiura; Naoyuki Fujimori; Soichiro Shibata; Yuki Ichikawa; Michiharu Komatsu; Akihiro Matsumoto; Koji Igarashi; Eiji Tanaka
Scientific reports, 7, 46705-46705, Apr. 2017 - Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Takefumi Kimura; Akira Kobayashi; Naoki Tanaka; Kenji Sano; Michiharu Komatsu; Naoyuki Fujimori; Tomoo Yamazaki; Soichiro Shibata; Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Akira Horiuchi; Hiromitsu Mori; Shuichi Wada; Kendo Kiyosawa; Shin-Ichi Miyagawa; Eiji Tanaka
Hepatology research : the official journal of the Japan Society of Hepatology, 47(5), 405-418, Apr. 2017 - Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Yugo Shobugawa; Yoko Usami; Soichiro Shibata; Tomoo Yamazaki; Naoyuki Fujimori; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
Hepatology research : the official journal of the Japan Society of Hepatology, 47(2), 226-233, Feb. 2017 - Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis.
Tomoo Yamazaki; Yasuhide Ochi; Naoki Tanaka; Takayuki Watanabe; Yugo Iwaya; Ayako Seki; Etsuo Hara; Eiji Tanaka; Tomoharu Watanabe; Shun Imai; Osamu Hasebe
Clinical journal of gastroenterology, 10(1), 73-78, Feb. 2017 - Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
Hiroyuki Kitabatake; Naoki Tanaka; Naoyuki Fujimori; Michiharu Komatsu; Ayaka Okubo; Kyogo Kakegawa; Takefumi Kimura; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Masayoshi Koinuma; Kenji Sano; Toshifumi Aoyama; Eiji Tanaka
World journal of gastroenterology, 23(4), 712-722, Jan. 2017 - Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.
Naoyuki Fujimori; Naoki Tanaka; Soichiro Shibata; Kenji Sano; Tomoo Yamazaki; Tomohiro Sekiguchi; Hiroyuki Kitabatake; Yuki Ichikawa; Takefumi Kimura; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Hepatology research : the official journal of the Japan Society of Hepatology, 46(10), 1019-27, Sep. 2016 - Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
Soichiro Shibata; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
Hepatology research : the official journal of the Japan Society of Hepatology, 46(9), 884-9, Aug. 2016 - A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma.
Tomoo Yamazaki; Yugo Iwaya; Mai Iwaya; Takayuki Watanabe; Ayako Seki; Yasuhide Ochi; Etsuo Hara; Tomohiro Sekiguchi; Noriko Hosaka; Norikazu Arakura; Eiji Tanaka; Osamu Hasebe
Clinical journal of gastroenterology, 9(4), 222-7, Aug. 2016 - Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan.
Takeji Umemura; Satoru Joshita; Tomoo Yamazaki; Michiharu Komatsu; Yoshihiko Katsuyama; Kaname Yoshizawa; Eiji Tanaka; Masao Ota
Scientific reports, 6, 29770-29770, Jul. 2016 - Case of Barrett's adenocarcinoma with marked endoscopic morphological changes in Barrett's esophagus over a long follow-up period of 15 years.
Yugo Iwaya; Tomoo Yamazaki; Takayuki Watanabe; Ayako Seki; Yasuhide Ochi; Etsuo Hara; Norikazu Arakura; Eiji Tanaka; Osamu Hasebe
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 28(5), 607-10, Jul. 2016 - Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.
Soichiro Shibata; Satoru Joshita; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Yuki Ichikawa; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
SpringerPlus, 5(1), 998-998, 2016
Research Themes
- バクテリオファージによるアルコール性肝炎の精密治療
海外留学助成リサーチフェローシップ, 上原記念生命科学振興財団
2022 - C型肝炎SVR後発癌に関連する因子の検討
研究助成金, アッヴィ合同会社
2021 - Analysis of gastrointestinal autoimmune diseases onset and the diversity of HLA antigen expression.
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Grant-in-Aid for Early-Career Scientists
Shinshu University
01 Apr. 2020 - 31 Mar. 2022 - 肝疾患におけるT細胞受容体とB細胞受容体のレパトア解析
若手医師プロジェクト支援事業, アイバワークス
2017 - C型慢性肝炎患者におけるAutotaxinの肝線維化マーカーとしての有用性の検討
信州医学振興会
2016
